Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 873 M837 M884 M874 M 3.47 B Research & development ———— — Operating income 1.18 B1.18 B1.23 B1.47 B 5.07 B Non-Operating Income, Total -42 M-12 M-11 M-39 M -104 M Interest expense, net of interest capitalized 101 M106 M99 M95 M 401 M Non-Operating Income, excl. Interest Expenses -149 M-88 M-96 M-101 M -434 M Unusual income/expense 107 M76 M85 M62 M 330 M Pretax income 1.04 B1.06 B1.12 B1.34 B 4.56 B Equity in earnings 58 M51 M53 M56 M 218 M Taxes 232 M219 M215 M248 M 914 M Non-controlling/minority interest ——01 M — After tax other income/expense 16 M3 M18 M-13 M 24 M Net income before discontinued operations 808 M845 M904 M1.09 B 3.65 B Discontinued operations ———— — Net income 808 M845 M904 M1.09 B 3.65 B Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 808 M845 M904 M1.09 B 3.65 B Basic earnings per share (Basic EPS) 6.396.697.168.65 28.89 Diluted earnings per share (Diluted EPS) 6.296.67.0627.31 28.48 Average basic shares outstanding 126.5 M126.2 M126.2 M126.3 M — Diluted shares outstanding 128.4 M128.1 M128 M128.1 M — EBITDA 2.01 B2.04 B2.14 B— — EBIT 1.77 B1.8 B1.9 B— — Cost of revenue 3.18 B3.24 B3.47 B3.51 B 13.4 B Other cost of goods sold ———— — Depreciation & amortization (cash flow) 232 M233 M235 M584 M 1.28 B